The study identifies ligand–receptor pairs conserved in humans and altered in MS and Alzheimer’s.
Makes me also wonder how many could be druggable targets.
The study identifies ligand–receptor pairs conserved in humans and altered in MS and Alzheimer’s.
Makes me also wonder how many could be druggable targets.
Great study that maps cell-type-specific regulomes showing that small vessel disease heritability spans the neurovascular unit, incl astrocytes.
These findings link vascular risk and Alzheimer’s mechanisms.
Great study that maps cell-type-specific regulomes showing that small vessel disease heritability spans the neurovascular unit, incl astrocytes.
These findings link vascular risk and Alzheimer’s mechanisms.
www.mdpi.com/1422-0067/26...
www.mdpi.com/1422-0067/26...
cell.com/cell-stem-ce...
cell.com/cell-stem-ce...
x.com/rust_ruslan/...
x.com/rust_ruslan/...
Our new study in NatureComms @natureportfolio.nature.com shows that they can and dissect the key mechanisms driving recovery.
t.co/KRfAHfkNIH
Our new study in NatureComms @natureportfolio.nature.com shows that they can and dissect the key mechanisms driving recovery.
t.co/KRfAHfkNIH
Transplanted into pericyte-deficient mice, they formed hybrid human-mouse microvessels🐭
biorxiv.org/content/10.1...
Transplanted into pericyte-deficient mice, they formed hybrid human-mouse microvessels🐭
biorxiv.org/content/10.1...
One option is to enhance the clerance function for neurotoxic proteins at the BBB e.g. targeting lipoprotein receptors (LRP)
One option is to enhance the clerance function for neurotoxic proteins at the BBB e.g. targeting lipoprotein receptors (LRP)
tandfonline.com/doi/10.1080/...
TL;DR → Here are a few key highlights 👇
tandfonline.com/doi/10.1080/...
TL;DR → Here are a few key highlights 👇
@brain1878.bsky.social
We explore how molecular blood-brain barrier (BBB) changes in aging, neurodegeneration and stroke affect disease progression, delivery of therapeutics, and much more!
academic.oup.com/brain/advanc...
@brain1878.bsky.social
We explore how molecular blood-brain barrier (BBB) changes in aging, neurodegeneration and stroke affect disease progression, delivery of therapeutics, and much more!
academic.oup.com/brain/advanc...
Our latest preprint shows that delaying NPC therapy by one week post-stroke increases long-term graft survival 20-fold.
www.biorxiv.org/content/10.1...
Our latest preprint shows that delaying NPC therapy by one week post-stroke increases long-term graft survival 20-fold.
www.biorxiv.org/content/10.1...
We invite you to evaluate the DeepSeek R1 preprint at
@researchhubf.bsky.social , and reward high-quality contributions with 150$ (in RSC).
researchhub.com/paper/916140...
We invite you to evaluate the DeepSeek R1 preprint at
@researchhubf.bsky.social , and reward high-quality contributions with 150$ (in RSC).
researchhub.com/paper/916140...